GNT0003

· Genethon

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GNT0003, covering 2024-12-03 to 2024-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome [Phase 2]